Global Amebiasis Market Research Report 2020
1 Amebiasis Market Overview
- 1.1 Product Overview and Scope of Amebiasis
- 1.2 Amebiasis Segment by Type
- 1.2.1 Global Amebiasis Sales Growth Rate Comparison by Type (2020-2026)
- 1.2.2 Metronidazole
- 1.2.3 Paromomycin
- 1.2.4 Tinidazole
- 1.2.5 Other
- 1.3 Amebiasis Segment by Application
- 1.3.1 Amebiasis Sales Comparison by Application: (2020-2026)
- 1.3.2 Hospital
- 1.3.3 Pharmacy
- 1.4 Global Amebiasis Market Size Estimates and Forecasts
- 1.4.1 Global Amebiasis Revenue 2015-2026
- 1.4.2 Global Amebiasis Sales 2015-2026
- 1.4.3 Amebiasis Market Size by Region: 2020 Versus 2026
2 Global Amebiasis Market Competition by Manufacturers
- 2.1 Global Amebiasis Sales Market Share by Manufacturers (2015-2020)
- 2.2 Global Amebiasis Revenue Share by Manufacturers (2015-2020)
- 2.3 Global Amebiasis Average Price by Manufacturers (2015-2020)
- 2.4 Manufacturers Amebiasis Manufacturing Sites, Area Served, Product Type
- 2.5 Amebiasis Market Competitive Situation and Trends
- 2.5.1 Amebiasis Market Concentration Rate
- 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
- 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
- 2.7 Primary Interviews with Key Amebiasis Players (Opinion Leaders)
3 Amebiasis Retrospective Market Scenario by Region
- 3.1 Global Amebiasis Retrospective Market Scenario in Sales by Region: 2015-2020
- 3.2 Global Amebiasis Retrospective Market Scenario in Revenue by Region: 2015-2020
- 3.3 North America Amebiasis Market Facts & Figures by Country
- 3.3.1 North America Amebiasis Sales by Country
- 3.3.2 North America Amebiasis Sales by Country
- 3.3.3 U.S.
- 3.3.4 Canada
- 3.4 Europe Amebiasis Market Facts & Figures by Country
- 3.4.1 Europe Amebiasis Sales by Country
- 3.4.2 Europe Amebiasis Sales by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific Amebiasis Market Facts & Figures by Region
- 3.5.1 Asia Pacific Amebiasis Sales by Region
- 3.5.2 Asia Pacific Amebiasis Sales by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.5.12 Philippines
- 3.5.13 Vietnam
- 3.6 Latin America Amebiasis Market Facts & Figures by Country
- 3.6.1 Latin America Amebiasis Sales by Country
- 3.6.2 Latin America Amebiasis Sales by Country
- 3.6.3 Mexico
- 3.6.4 Brazil
- 3.6.5 Argentina
- 3.7 Middle East and Africa Amebiasis Market Facts & Figures by Country
- 3.7.1 Middle East and Africa Amebiasis Sales by Country
- 3.7.2 Middle East and Africa Amebiasis Sales by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 U.A.E
4 Global Amebiasis Historic Market Analysis by Type
- 4.1 Global Amebiasis Sales Market Share by Type (2015-2020)
- 4.2 Global Amebiasis Revenue Market Share by Type (2015-2020)
- 4.3 Global Amebiasis Price Market Share by Type (2015-2020)
- 4.4 Global Amebiasis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Amebiasis Historic Market Analysis by Application
- 5.1 Global Amebiasis Sales Market Share by Application (2015-2020)
- 5.2 Global Amebiasis Revenue Market Share by Application (2015-2020)
- 5.3 Global Amebiasis Price by Application (2015-2020)
6 Company Profiles and Key Figures in Amebiasis Business
- 6.1 Dr. Reddy’s Laboratories
- 6.1.1 Corporation Information
- 6.1.2 Dr. Reddy’s Laboratories Description, Business Overview
- 6.1.3 Dr. Reddy’s Laboratories Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.1.4 Dr. Reddy’s Laboratories Products Offered
- 6.1.5 Dr. Reddy’s Laboratories Recent Development
- 6.2 Mission Pharmacal
- 6.2.1 Mission Pharmacal Corporation Information
- 6.2.2 Mission Pharmacal Description, Business Overview
- 6.2.3 Mission Pharmacal Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.2.4 Mission Pharmacal Products Offered
- 6.2.5 Mission Pharmacal Recent Development
- 6.3 Aceto Corporation
- 6.3.1 Aceto Corporation Corporation Information
- 6.3.2 Aceto Corporation Description, Business Overview
- 6.3.3 Aceto Corporation Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.3.4 Aceto Corporation Products Offered
- 6.3.5 Aceto Corporation Recent Development
- 6.4 Mylan Pharmaceuticals
- 6.4.1 Mylan Pharmaceuticals Corporation Information
- 6.4.2 Mylan Pharmaceuticals Description, Business Overview
- 6.4.3 Mylan Pharmaceuticals Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.4.4 Mylan Pharmaceuticals Products Offered
- 6.4.5 Mylan Pharmaceuticals Recent Development
- 6.5 Impax Laboratories
- 6.5.1 Impax Laboratories Corporation Information
- 6.5.2 Impax Laboratories Description, Business Overview
- 6.5.3 Impax Laboratories Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.5.4 Impax Laboratories Products Offered
- 6.5.5 Impax Laboratories Recent Development
- 6.6 Pfizer
- 6.6.1 Pfizer Corporation Information
- 6.6.2 Pfizer Description, Business Overview
- 6.6.3 Pfizer Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.6.4 Pfizer Products Offered
- 6.6.5 Pfizer Recent Development
- 6.7 Sanofi
- 6.6.1 Sanofi Corporation Information
- 6.6.2 Sanofi Description, Business Overview
- 6.6.3 Sanofi Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.4.4 Sanofi Products Offered
- 6.7.5 Sanofi Recent Development
- 6.8 Lupin Pharmaceuticals
- 6.8.1 Lupin Pharmaceuticals Corporation Information
- 6.8.2 Lupin Pharmaceuticals Description, Business Overview
- 6.8.3 Lupin Pharmaceuticals Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.8.4 Lupin Pharmaceuticals Products Offered
- 6.8.5 Lupin Pharmaceuticals Recent Development
- 6.9 Glenmark Pharmaceuticals
- 6.9.1 Glenmark Pharmaceuticals Corporation Information
- 6.9.2 Glenmark Pharmaceuticals Description, Business Overview
- 6.9.3 Glenmark Pharmaceuticals Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.9.4 Glenmark Pharmaceuticals Products Offered
- 6.9.5 Glenmark Pharmaceuticals Recent Development
- 6.10 Sun Pharmaceutical
- 6.10.1 Sun Pharmaceutical Corporation Information
- 6.10.2 Sun Pharmaceutical Description, Business Overview
- 6.10.3 Sun Pharmaceutical Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.10.4 Sun Pharmaceutical Products Offered
- 6.10.5 Sun Pharmaceutical Recent Development
- 6.11 Heritage Pharmaceuticals
- 6.11.1 Heritage Pharmaceuticals Corporation Information
- 6.11.2 Heritage Pharmaceuticals Amebiasis Description, Business Overview
- 6.11.3 Heritage Pharmaceuticals Amebiasis Sales, Revenue and Gross Margin (2015-2020)
- 6.11.4 Heritage Pharmaceuticals Products Offered
- 6.11.5 Heritage Pharmaceuticals Recent Development
7 Amebiasis Manufacturing Cost Analysis
- 7.1 Amebiasis Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Raw Materials Price Trend
- 7.1.3 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of Amebiasis
- 7.4 Amebiasis Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Amebiasis Distributors List
- 8.3 Amebiasis Customers
9 Market Dynamics
- 9.1 Market Trends
- 9.2 Opportunities and Drivers
- 9.3 Challenges
- 9.4 Porter's Five Forces Analysis
10 Global Market Forecast
- 10.1 Global Amebiasis Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Amebiasis by Type (2021-2026)
- 10.1.2 Global Forecasted Revenue of Amebiasis by Type (2021-2026)
- 10.2 Amebiasis Market Estimates and Projections by Application
- 10.2.1 Global Forecasted Sales of Amebiasis by Application (2021-2026)
- 10.2.2 Global Forecasted Revenue of Amebiasis by Application (2021-2026)
- 10.3 Amebiasis Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of Amebiasis by Region (2021-2026)
- 10.3.2 Global Forecasted Revenue of Amebiasis by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Amebiasis market is segmented into
Metronidazole
Paromomycin
Tinidazole
Other
Segment by Application
Hospital
Pharmacy
Global Amebiasis Market: Regional Analysis
The Amebiasis market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Amebiasis market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Amebiasis Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Amebiasis market include:
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals